Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Classificação em ações #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Preço da ação
$0.12164306
Última sincronização: 2024-11-11
Valor de mercado
$38.53M
Variação (1 dia)
-4.14%
Variação (1 ano)
0.00%
País
AU
Negociar PharmAust Limited (PAA)

Categoria

Receita da PharmAust Limited (PAA)
Receita em Jun 2024 TTM: $572.45K
De acordo com os últimos relatórios financeiros da PharmAust Limited, a receita atual da empresa (TTM) é $572.45K. Em 2023, a empresa obteve uma receita de $1.88M uma diminuição em relação a a receita do ano 2022, que foi de $2.33M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da PharmAust Limited de 2001 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $572.45K 0.00%
2024 0.00 -100.00%
2023 $1.88M -19.32%
2022 $2.33M 45.33%
2021 $1.60M -27.22%
2020 $2.21M -27.76%
2019 $3.05M 26.47%
2018 $2.41M -5.23%
2017 $2.55M 25.80%
2016 $2.02M 10.90%
2015 $1.83M -0.20%
2014 $1.83M 17.05%
2013 $1.56M -5.48%
2012 $1.65M -0.67%
2011 $1.66M 19.79%
2010 $1.39M -2.17%
2009 $1.42M -47.01%
2008 $2.68M -55.73%
2007 $6.05M 33.53%
2006 $4.53M 85.63%
2005 $2.44M 1,047.74%
2004 $212.83K 366.98%
2003 $45.58K -88.07%
2002 $381.98K 0.00%
2001 0.00 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$12.62B 2,205,224.96%
US
$6.02B 1,051,752.00%
NL
$15.70B 2,741,683.32%
AU
$2.23B 389,106.85%
US
- -
CH